Accele Biopharma is an Oklahoma-based venture capital accelerator program for fledgling drug developers preparing to launch in Oklahoma City. The firm seeks to create a capital-efficient mechanism to identify, finance, and manage groundbreaking early-stage life science technologies that have the potential to dramatically improve human healthcare, have strong commercial promise and have the potential for generating early proof of concept data.
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.